Table 3.
The percentage of gated large cells (in R2) expressing CD4+, CD8+ and CD16/56+ surface markers following stimulation of PBMC from active cutaneous leishmaniasis patients with LACK and Ft-Leish
| %CD4+/CD8− | %CD8+/CD4− | CD16/56+/CD3− | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Sample | RPMI | LACK | Ft-Leish | RPMI | LACK | Ft-Leish | RPMI | LACK | Ft-Leish |
| P1 | 56·10 | 17·15 | 60·67 | 19·51 | 31·44 | 11·41 | 0·76 | 57·01 | 18·47 |
| P2 | 51·93 | 14·91 | 26·28 | 14·39 | 26·82 | 26·28 | 6·39 | 37·25 | 8·07 |
| P3 | 42·53 | 13·86 | 9·67 | 24·14 | 71·75 | 40·86 | 7·25 | 53·52 | 40·86 |
| P4 | 51·91 | 71·34 | 72·44 | 9·16 | 10·44 | 8·71 | 4·32 | 8·73 | 4·53 |
| P5 | 35·02 | 23·08 | 78·76 | 12·73 | 28·54 | 6·34 | 0·53 | 11·42 | 1·93 |
| P6 | 31·88 | 16·23 | 27·45 | 13·04 | 36·07 | 19·24 | 15·38 | 37·81 | 38·35 |
| P7 | 18·00 | 6·33 | 25·39 | 10·00 | 64·84 | 53·48 | 11·25 | 34·01 | 13·06 |
| P8 | 51·91 | 71·34 | 72·44 | 9·16 | 10·44 | 8·71 | 4·32 | 8·73 | 4·53 |
| P9 | 51·91 | 71·34 | 72·44 | 9·16 | 10·44 | 8·71 | 4·32 | 8·73 | 4·53 |
| P10 | 54·12 | 24·96 | 65·33 | 3·61 | 21·35 | 15·19 | 1·12 | 36·28 | 8·30 |